![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, March 02, 2023 10:22:53 AM
As far as management is concerned, even now I think they have us positioned to begin enjoying success. And beyond that, they have twice shown me exceptional personal consideration as a shareholder. They're good and gifted people, Yooo. And lenz is a miraculous drug. No drug in this programmable pandemic can stop the effect of the virus better than lenz.
I can relate to the intolerable disappointment and disillusionment many shareholders feel, as I feel it, too. Sometimes, that's all too obvious in my posts. But our success with lenz is going to have a major impact on the treatment market for many indications, and Big Pharma faces losses of market share for all of those indications. They do not want the NIH and FDA to let us succeed.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM